Eaton Financial Holdings Company, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Eaton Financial Holdings Company, LLC
- $325 Billion
- Q2 2025
A detailed history of Eaton Financial Holdings Company, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Eaton Financial Holdings Company, LLC holds 941 shares of REGN stock, worth $531,316. This represents 0.15% of its overall portfolio holdings.
Number of Shares
941Holding current value
$531,316% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,420Shares Held
88.7MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.32 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.77 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.19 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.73 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.16 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $60.5B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...